#LaurusBio
2 سلاسل التغريدات
#LaurusLabs Q3FY22 Earnings Analysis In depth attempt to understand beyond the numbers 🧵⤵️ https://t.co/cjoJXAznBS
Why did #LaurusLabs bought a significant minority stake (26.62%) in a cell and gene therapy startup (ImmunoACT)? A short thread 🧵👇🏽⤵️ https://t.co/eVjJVD2kA9